Price $48.60 |
Market Cap
6.5B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
35.8
|
P/B
7.17
|
P/S
3.4
|
Dividend %
0.40%
|
|
P/CF
442.0
|
P/FCF
49.1
|
Op. Cash Flow
210.1K
|
FCF
0.8
|
|
Op. Margin
13.80%
|
Net Margin
9.50%
|
ROE
21.60%
|
ROI
16.10%
|
|
ROA
9.10%
|
EPS Growth
120.10%
|
Current Ratio
2.2
|
Debt/Equity
36.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Harvard Bioscience, Inc. (HBIO) | $2.04 | - | - | 87.4M | Strong Buy |
| ImmuCell Corporation (ICCC) | $6.60 | - | - | 44.5M | Strong Buy |
| Streamline Health Solutions In (STRM) | $1.83 | - | - | 26.4M | Strong Buy |
| Bausch Health Companies Inc (BHC) | $23.76 | - | - | 7.55B | Strong Buy |
| Milestone Scientific Inc. (MLSS) | $0.33 | - | - | 13.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
